-
Pandemic accelerates at-home testing development for other medical conditions
Developers are pursuing rapid flu and strep-throat diagnostic products as the pandemic raised consumers' comfort level with monitoring their own health, The Wall Street Journal reported March 3. -
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week: -
3 indirect threats Russia-Ukraine conflict poses for hospital supplies
The impact of the Russia-Ukraine conflict on global supply chain operations will likely depend on sanctions applied by the West and retaliation from Russia, according to a new report from Premier. -
2 Florida men charged in $11M medical supply fraud scheme
Two Florida men were arrested on charges that alleged they illegally bought and sold prescriptions for durable medical equipment and used those prescriptions to file fraudulent Medicare claims for more than $11 million, the U.S. Justice Department said March 1. -
FDA warns against 3 at-home COVID-19 tests
The FDA issued warnings against using three at-home COVID-19 tests that have not been authorized by the agency over the risk of false results. -
Common at-home tests effective at detecting omicron, early study finds
Several widely used rapid antigen at-home COVID-19 tests are effective at detecting omicron, according to preliminary research published Feb. 28 in MedRxiv. -
Supply Chain Tip of the Week: 3 key components of a contingency stock plan
The ongoing COVID-19 pandemic and supply challenges have shown the need for contingency stock plans that allow you to continue delivering quality patient care while navigating inventory crises. This involves the three following components: -
US transplant system needs an overhaul, advisory panel says
While a record-breaking 41,354 organ transplants were performed in the U.S. last year, the nation's current organ transplantation system is inequitable, and more can be done to boost that number, according to a report published Feb. 25 from the National Academies of Sciences, Engineering and Medicine. -
Former medical supply company owner sentenced in fraud scheme
A former medical supply company owner in Virginia Beach, Va., has been sentenced to 51 months in prison in connection with a multimillion dollar healthcare fraud scheme, the U.S. Justice Department said Feb. 24. -
Arrow International recalls thrombolytic devices over detachment issues
Arrow International recalled over 24,000 percutaneous thrombolytic devices due to risk of tip damage during use, which could result in tip detachment from the basket. -
White House releases plan to strengthen supply chain
The Biden administration released long-term actions it plans to take to boost supply chain resiliency Feb. 24. -
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week: -
17 rapid COVID-19 tests approved for use at home
The FDA released a list of 17 rapid COVID-19 at-home tests Feb. 22 that are authorized by the agency. -
Medtronic donating AI colonoscopy tech to underserved communities
Medtronic and the American Society for Gastrointestinal Endoscopy are partnering to provide endoscopy centers in underserved communities with AI-assisted colonoscopy tools to allow better access to colon cancer screenings. -
Fortune's 5 most influential medical distributors
McKesson ranked seventh on Fortune's annual list of the 500 most profitable U.S. companies in 2020, making it the top-ranked medical distributor. -
7 pandemic lessons on supply chain visibility
More than 60 supply chain experts from 34 organizations gathered for the Health Industry Distributors Association’s Supply Chain Visibility Conference to discuss best practices learned from the pandemic. -
5 recent medical device recalls
Medical device recalls, whether voluntary or mandated by the FDA, ensure patient safety. -
US distributors opting for trucks over trains amid supply-chain bottlenecks
Distributors are increasingly looking to highways instead of railroads for transportation to get around bottlenecks and avoid delays, The Wall Street Journal reported Feb. 21. -
5 states with the largest supply of omicron-effective antibody
Nearly 49,000 courses of Eli Lilly's bebtelovimab — a monoclonal antibody treatment effective against omicron — have been distributed throughout the U.S. since the FDA issued an emergency use authorization for the drug Feb. 11. -
Family Dollar recalls drugs, devices shipped from rodent-infested Arkansas facility
Family Dollar recalled products shipped to 404 stores after a rodent infestation was discovered in a West Memphis, Ark.-based distribution center.
Page 38 of 50